Optimizing Care for Patients With Endometrial Cancer: A Focus on Pharmacist Interventions

Program Description

The use of immunotherapies and targeted therapies has shifted management strategies for patients with endometrial cancer. Expert faculty will share perspectives on the impact of biomarker testing on treatment selection of immunotherapy and targeted therapy. Updated guideline recommendations for patients with endometrial cancer will be discussed. This podcast will also explore strategies pharmacists may use to mitigate and manage drug-related adverse effects of immune checkpoint inhibitors and targeted agents.

Target audience: Oncology pharmacists

Type of activity: Knowledge
Release date: June 30, 2022
Expiration date: June 30, 2023

Time to complete activity: 0.5 hour
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Recognize the role of biomarker expression in the selection of most appropriate treatment options for patients with endometrial cancer
• Review strategies for identification and management of drug-related toxicities in patients receiving therapy with immune checkpoint inhibitors, targeted agents, or combination therapy

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-22-322-H01-P. The activity is available for CE credit through June 30, 2023.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, listen to the podcast in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Faculty

Sarah Hayward, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose:

Consultant (advisory board): GSK, Seagen/Genmab

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Evelina Kolychev, PharmD, BCOP; Kylie Ferrentino; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose.

Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms